Early detection of medication-related osteonecrosis of the jaw (MRONJ) in patients with metastatic breast cancer using FDG-PET/CT scans

Key Points

• Early detection of medication-related osteonecrosis of the jaw was made possible using FDG-PET/CT scans, enhancing patient care.
• Specific imaging techniques can identify osteonecrosis early in patients with metastatic breast cancer, which is crucial for effective treatment.
• Assessment using FDG-PET/CT scans revealed notable imaging features supporting diagnosis and monitoring.
• Findings may enable improved preventative strategies in clinical settings, though further research is needed for broader application.